Literature DB >> 8910586

cDNA cloning and characterization of the human interleukin 13 receptor alpha chain.

M J Aman1, N Tayebi, N I Obiri, R K Puri, W S Modi, W J Leonard.   

Abstract

We have cloned cDNAs corresponding to the human interleukin 13 receptor alpha chain (IL-13Ralpha). The protein has 76% homology to murine IL-13Ralpha, with 95% amino acid identity in the cytoplasmic domain. Only weak IL-13 binding activity was found in cells transfected with only IL-13Ralpha; however, the combination of both IL-13Ralpha and IL-4Ralpha resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the IL-13 receptor. Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for IL-4 signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity. Nevertheless, the overall size and length of the cytoplasmic domain of IL-13Ralpha and gammac are similar, and like gammac, IL-13Ralpha is located on chromosome X.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910586     DOI: 10.1074/jbc.271.46.29265

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Authors:  Umasundari Sivaprasad; Manoj R Warrier; Aaron M Gibson; Weiguo Chen; Yasuhiro Tabata; Stacey A Bass; Marc E Rothenberg; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

3.  Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.

Authors:  M R Potter; N Noben-Trauth; J H Weis; C Teuscher; J J Weis
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

5.  Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Authors:  C Doucet; D Brouty-Boyé; C Pottin-Clémenceau; G W Canonica; C Jasmin; B Azzarone
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.

Authors:  Andrea Formentini; Philipp Braun; Harald Fricke; Karl-Heinrich Link; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Colorectal Dis       Date:  2012-03-24       Impact factor: 2.571

7.  IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.

Authors:  Weiguo Chen; Umasundari Sivaprasad; Yasuhiro Tabata; Aaron M Gibson; Matthew T Stier; Fred D Finkelman; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 8.  How does high-fat diet induce adipose tissue fibrosis?

Authors:  Jeffrey E Pessin; Hyokjoon Kwon
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

9.  Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.

Authors:  Daniel Myrtek; Mathias Knoll; Timm Matthiesen; Sebastian Krause; Jens Lohrmann; Dirk Schillinger; Marco Idzko; J Christian Virchow; Karlheinz Friedrich; Werner Luttmann
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

10.  Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression.

Authors:  Wei Liao; Dustin E Schones; Jangsuk Oh; Yongzhi Cui; Kairong Cui; Tae-Young Roh; Keji Zhao; Warren J Leonard
Journal:  Nat Immunol       Date:  2008-09-28       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.